Rabbit Recombinant Multiclonal iNOS antibody. Carrier free. Suitable for IP, Flow Cyt (Intra), WB, IHC-P, I-ELISA, ICC/IF and reacts with Mouse, Human, Rat, Recombinant fragment - Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
IP | Flow Cyt (Intra) | WB | IHC-P | I-ELISA | ICC/IF | IHC-Fr | |
---|---|---|---|---|---|---|---|
Human | Tested | Tested | Tested | Tested | Expected | Not recommended | Not recommended |
Mouse | Tested | Tested | Tested | Not recommended | Expected | Tested | Not recommended |
Rat | Expected | Expected | Tested | Not recommended | Expected | Expected | Not recommended |
Recombinant fragment - Human | Not recommended | Not recommended | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes We have preliminary internal testing data to indicate this antibody showed no staining in mouse and rat tissue samples by IHC-P |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes We have preliminary internal testing data to indicate this antibody showed no staining in mouse and rat tissue samples by IHC-P |
Species Mouse | Dilution info - | Notes We have preliminary internal testing data to indicate this antibody showed no staining in mouse and rat tissue samples by IHC-P |
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes We have preliminary internal testing data to indicate this antibody may not be suitable for human ICC/IF |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes We have preliminary internal testing data to indicate this antibody may not be suitable for human ICC/IF |
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human, Recombinant fragment - Human | Dilution info - | Notes - |
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7504305, PubMed:7531687, PubMed:7544004, PubMed:7682706). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM (PubMed:25417112). Involved in inflammation, enhances the synthesis of pro-inflammatory mediators such as IL6 and IL8 (PubMed:19688109).
NOS2A, NOS2, Hepatocyte NOS, Inducible NO synthase, NOS type II, Peptidyl-cysteine S-nitrosylase NOS2, HEP-NOS, Inducible NOS, iNOS
Rabbit Recombinant Multiclonal iNOS antibody. Carrier free. Suitable for IP, Flow Cyt (Intra), WB, IHC-P, I-ELISA, ICC/IF and reacts with Mouse, Human, Rat, Recombinant fragment - Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
We have preliminary internal testing data to indicate this antibody may not be suitable for human ICC/IF and showed no staining in mouse and rat tissue samples by IHC-P.
FURTHER INFORMATION ON SPECIFICITY (Chinese Version) available under the support & downloads section.
ab283668 is the carrier-free version of Anti-iNOS antibody [RM1017] ab283655.
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Inducible Nitric Oxide Synthase commonly referred to as iNOS or NOS2 is an important enzyme in the production of nitric oxide (NO) from L-arginine. This enzyme has a molecular weight of approximately 130 kDa and is expressed in various cell types including macrophages and hepatocytes. iNOS becomes active in response to inflammatory stimuli and can produce large amounts of NO for extended periods. Western blotting and iNOS ELISA kits are frequently used methods to detect and quantify the presence and activity of iNOS in different biological samples.
INOS plays a significant role in the immune system by participating in the defense against pathogens. The enzyme is part of a molecular complex that generates NO which acts as a signaling molecule and has antimicrobial properties. iNOS activity is induced during immune responses and contributes to the elimination of bacteria and viruses through the production of reactive nitrogen species. Its expression is tightly regulated by cytokines and other signaling molecules that modulate the extent of its action.
INOS integrates into the nitric oxide signaling pathway and is closely associated with inflammatory pathways. NO serves as a messenger within the nitric oxide signaling pathway facilitating processes like vasodilation and neurotransmission. iNOS works alongside other proteins such as cytokines like interferon-gamma that elevate its activity during inflammation and immune responses. The regulation of iNOS expression and activity plays an essential role in maintaining immune homeostasis and ensuring proper response to infections.
INOS is linked to conditions characterized by excessive inflammation such as rheumatoid arthritis and sepsis. In these diseases overproduction of nitric oxide by iNOS can lead to tissue damage and exacerbate symptoms. Additionally iNOS is associated with the protein TNF-alpha as its expression is often driven by inflammatory mediators during disease states. Understanding the role of iNOS in such conditions provides insights into potential therapeutic targets for managing inflammatory diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
iNOS was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 1μg/ml LPS for 6h whole cell lysate 10μg with Anti-iNOS antibody [RM1017] ab283655 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-iNOS antibody [RM1017] ab283655 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 1μg/ml LPS for 6h whole cell lysate 10μg
Lane 2: Anti-iNOS antibody [RM1017] ab283655 IP in RAW 264.7 treated with 1μg/ml LPS for 6h whole cell lysate
Lane 3:Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-iNOS antibody [RM1017] ab283655 in RAW 264.7 treated with 1μg/ml LPS for 6h whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 8 seconds
Lower bands could be proteolytic cleavage as described in literature. (PMID: 11786228)
All lanes: Immunoprecipitation - Anti-iNOS antibody [RM1017] (Anti-iNOS antibody [RM1017] ab283655)
Predicted band size: 131 kDa
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human lung tissue labeling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/2000 (0.3 μg/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Positive staining on the human lung. The section was incubated with Anti-iNOS antibody [RM1017] ab283655 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/2000 (0.3 μg/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Positive staining on the hepatocytes in human liver. The section was incubated with Anti-iNOS antibody [RM1017] ab283655 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized Caco-2 (Human colorectal adenocarcinoma epithelial cell) cells labelling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/600 dilution (0.1μg) (Red) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human lung carcinoma tissue labeling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/2000 (0.3 μg/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Positive staining on the human lung carcinoma. The section was incubated with Anti-iNOS antibody [RM1017] ab283655 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used.
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 cells labelling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/50 (12.0 μg/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 μg/ml) dilution (Green). Confocal image showing cytoplasmic staining in RAW 264.7 cell line after treatment with lipopolysaccharide ( 1μg/ml ) for 6 h. is observed. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5μg/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 1μg/ml LPS for 6h (Red) / Untreated control (Green) cells labelling iNOS with Anti-iNOS antibody [RM1017] ab283655 at 1/600 dilution (0.1μg) (Red) and Green (Red) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Indirect ELISA using Anti-iNOS antibody [RM1017] ab283655 at varying antibody concentrations and antigen concentration at 1000 ng/mL. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) (1/2500) was used as the secondary antibody.
Blocking buffer and concentration: 5% NFDM/TBST
iNOS is not normally expressed in the brain, but can be induced in the brain after inflammatory, infectious or other damages (PMID: 11138926, PMID: 16156895, PMID: 10322315).
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Lanes 1 - 3: Western blot - Anti-iNOS antibody [RM1017] (Anti-iNOS antibody [RM1017] ab283655) at 1/1000 dilution
Lanes 1 - 3: Western blot - Anti-iNOS antibody [RM1017] - BSA and Azide free (ab283668)
Lane 1: Mouse hippocampus tissue lysate at 20 µg
Lane 2: Mouse colon tissue lysate at 20 µg
Lane 3: Mouse colon cancer tissue lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 131 kDa
iNOS was immunoprecipitated from DLD-1 (human colorectal adenocarcinoma epithelial cell) treated with 100U/mL IFN gamma (human), 50U/mL IL-1 beta (human) and 10ng/mL TNF alpha for 24h whole cell lysate with Anti-iNOS antibody [RM1017] ab283655 at 1/30 dilution (2 μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-iNOS antibody [RM1017] ab283655 at 1/2000 dilution. VeriBlot for IP secondary antibody(HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: DLD-1 (human colorectal adenocarcinoma epithelial cell) treated with 100U/mL IFN gamma(human), 50U/mL IL-1 beta(human) and 10ng/mL TNF alpha for 24h whole cell lysate
Lane 2: Anti-YB1 antibody [RM1188] ab320005 IP in DLD-1 (human colorectal adenocarcinoma epithelial cell) treated with 100U/mL IFN gamma(human), 50U/mL IL-1 beta(human) and 10ng/mL TNF alpha for 24h whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-iNOS antibody [RM1017] ab283655 in DLD-1 treated with 100U/mL IFN gamma (human), 50U/mL IL-1 beta (human) and 10ng/mL TNF alpha for 24h whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST
All lanes: Immunoprecipitation - Anti-iNOS antibody [RM1017] (Anti-iNOS antibody [RM1017] ab283655) at 1/2000 dilution
All lanes: DLD-1 (human colorectal adenocarcinoma epithelial cell) treated with 100U/mL IFN gamma(human), 50U/mL IL-1 beta(human) and 10ng/mL TNF alpha for 24h whole cell lysate at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Predicted band size: 131 kDa
Observed band size: 131 kDa
Exposure time: 32s
This data was developed using Anti-iNOS antibody [RM1017] ab283655, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-iNOS antibody [RM1017] (Anti-iNOS antibody [RM1017] ab283655) at 1/2000 dilution
Lane 1: DLD-1 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: DLD-1 treated with 100U/mL IFN gamma(human), 50U/mL IL-1 beta(human) and 10ng/mL TNF alpha for 24h whole cell lysate at 20 µg
Lane 3: Caco-2 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4: RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 5: RAW 264.7 treated with 100ng/ml lipopolysaccharide (LPS) for 6h whole cell lysate at 20 µg
Lane 6: NR8383 (rat alveolar macrophage) whole cell lysate at 20 µg
Lane 7: NR8383 treated with 1ng/ml lipopolysaccharide (LPS) for 24h whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 131 kDa, 36 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com